Our experience in riboflavin and ultraviolet light pathogen reduction technology for platelets: from platelet production to patient care-Reference-Cited by-同舟云学术

Our experience in riboflavin and ultraviolet light pathogen reduction technology for platelets: from platelet production to patient care

Published:2018-08 Issue:8 Volume:58 Page:1881-1889
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Jimenez-Marco Teresa¹,Garcia-Recio Marta²,Girona-Llobera Enrique¹

Affiliation:

1. Fundació Banc de Sang i Teixits de les Illes Balears; Majorca Spain

2. Hospital Universitari Son Espases; Majorca Spain

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/trf.14797/fullpdf

Reference46 articles.

1. Towards pathogen inactivation of red blood cells and whole blood targeting viral DNA/RNA: design, technologies, and future prospects for developing countries;Drew;Blood Transfus,2017

2. Novel processes for inactivation of leukocytes to prevent transfusion-associated graft-versus-host disease;Corash;Bone Marrow Transplant,2004

3. Reduced alloimmunization in mice following repeated transfusion with pathogen-reduced platelets;Muench;Transfusion,2016

4. Understanding loss of donor white blood cell immunogenicity after pathogen reduction: mechanisms of action in ultraviolet illumination and riboflavin treatment;Jackman;Transfusion,2009

5. Hemovigilance survey of pathogen-reduced blood components in the Warsaw Region in the 2009 to 2013 period;Łetowska;Transfusion,2016

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Platelet Pathogen Reduction Technology—Should We Stay or Should We Go…?;Journal of Clinical Medicine;2024-09-10

2. Impact of Shelf-Life Extension on Platelet Availability: Results from an Inventory Management Modeling Study;Transfusion Medicine and Hemotherapy;2024-04-02

3. Comparison of transfusion-outcome in patients with massive bleeding receiving pathogen-reduced platelets prepared with two different technologies;Transfusion and Apheresis Science;2022-06

4. Is pathogen reduction an acceptable alternative to irradiation for risk mitigation of transfusion-associated graft versus host disease?;Transfusion and Apheresis Science;2022-04

5. In Vitro Comparative Study of Platelets Treated with Two Pathogen-Inactivation Methods to Extend Shelf Life to 7 Days;Pathogens;2022-03-11